Wolfe Research Maintains Outperform on Merck & Co, Raises Price Target to $180

Benzinga · 2d ago
Wolfe Research analyst Alexandria Hammond maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $155 to $180.